New Key Statistics Module, Z-Score and F-Score
XCNQ:METX Key Ratios
Market Cap C$ M | 103.53 |
Enterprise Value C$ M | 103.19 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 70.86 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | -- |
EPS (TTM) C$ | -0.30 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -14.89 |
EV-to-EBITDA | -14.89 |
PEG | -- |
Shares Outstanding M | 25.19 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | -- |
Current Ratio | -- |
ROA % (ttm) | -880.30 |
ROE % (ttm) | -989.01 |
ROIC % (ttm) | -3,804.08 |
Dividend Yield % | -- |
Altman Z-Score | -- |
XCNQ:METX Number of Guru Trades
XCNQ:METX Volume of Guru Trades
Gurus Latest Trades with XCNQ:METX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XCNQ:METX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ME Therapeutics Holding Inc Insider Transactions
No Available Data